266 related articles for article (PubMed ID: 10092158)
41. Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
Ann Intern Med; 2003 May; 138(10):I39. PubMed ID: 12755582
[No Abstract] [Full Text] [Related]
42. Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next?
Launer LJ
JAMA; 2003 Jun; 289(21):2865-7. PubMed ID: 12783919
[No Abstract] [Full Text] [Related]
43. The cox-2 inhibitors.
Strassels S
J Mass Dent Soc; 1999; 48(3):43-4. PubMed ID: 10808349
[No Abstract] [Full Text] [Related]
44. COX-2 inhibitors: a review.
Houston AM; Teach SJ
Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
[No Abstract] [Full Text] [Related]
45. COX-2: separating myth from reality.
McKenna F
Scand J Rheumatol Suppl; 1999; 109():19-29. PubMed ID: 10422543
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs)-what makes a NSAID good value for money?
Freemantle N
Rheumatology (Oxford); 2000 Mar; 39(3):232-4. PubMed ID: 10788528
[No Abstract] [Full Text] [Related]
47. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
Cronstein BN
Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
[TBL] [Abstract][Full Text] [Related]
48. Characteristics of COX2 inhibitors questioned.
Petit-Zeman S
Nat Rev Drug Discov; 2004 Sep; 3(9):726-7. PubMed ID: 15368654
[No Abstract] [Full Text] [Related]
49. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
50. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
Tindall E
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
[TBL] [Abstract][Full Text] [Related]
51. [Selective cyclooxygenase-2 inhibitor].
Hettich M; Thomae K
Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
[No Abstract] [Full Text] [Related]
52. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
53. The promise of coxibs: how far have we progressed?
Schumacher HR
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S1-4. PubMed ID: 11992742
[No Abstract] [Full Text] [Related]
54. [Comparative safety of traditional non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors].
Bannwarth B
Presse Med; 2002 Dec; 31(39 Pt 2):4S7-9. PubMed ID: 12518070
[TBL] [Abstract][Full Text] [Related]
55. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors].
Miehle W
Wien Med Wochenschr; 1999; 149(19-20):541-5. PubMed ID: 10637962
[TBL] [Abstract][Full Text] [Related]
56. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
Housholder GT; Chan JT
J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
[No Abstract] [Full Text] [Related]
57. Selective inhibitors of cyclooxygenase-2 (COX-2).
Talley JJ
Prog Med Chem; 1999; 36():201-34. PubMed ID: 10818674
[No Abstract] [Full Text] [Related]
58. Selective cyclooxygenase-2 inhibitor. Pharmacology and state of knowledge following commercial availability.
Schmidt H; Geisslinger G
Schmerz; 2001 Jun; 15(3):207-19. PubMed ID: 11810359
[No Abstract] [Full Text] [Related]
59. Anti-inflammatories for cardiovascular disease.
Masferrer JL; Needleman P
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12400-1. PubMed ID: 11058172
[No Abstract] [Full Text] [Related]
60. Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal anti-inflammatory drugs: a clinical consideration.
Kawai S
Inflamm Res; 1998 Oct; 47 Suppl 2():S102-6. PubMed ID: 9831331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
